Indication

Relapse Rate After Allo-HSCT

1 clinical trial

1 product

Clinical trial

Phase II Study ofFlu-Bu-Mel Conditioning Regimen for Patients With Myeloid Disease Undergoing Allogeneic Stem Cell Transplantation

Status: Completed, Estimated PCD: 2023-03-30

Product